EGFR806-CAR T cells selectively target a tumor-restricted EGFR epitope in glioblastoma

類似資料

• IMMU-03. UPDATES ON BRAINCHILD-01, -02, AND -03: PHASE 1 LOCOREGIONAL CAR T CELL TRIALS TARGETING HER2, EGFR, AND B7-H3 FOR CHILDREN WITH RECURRENT CNS TUMORS AND DIPG
  著者:: Vitanza, Nicholas, 等
  出版事項: (2020)
• IMMU-11. CLINICAL UPDATES AND CORRELATIVE FINDINGS FROM THE FIRST PATIENT WITH DIPG TREATED WITH INTRACRANIAL CAR T CELLS
  著者:: Vitanza, Nicholas, 等
  出版事項: (2021)
• Engineering and characterisation of chimeric monoclonal antibody 806 (ch806) for targeted immunotherapy of tumours expressing de2-7 EGFR or amplified EGFR
  著者:: Panousis, C, 等
  出版事項: (2005)
• Targeting a unique EGFR epitope with monoclonal antibody 806 activates NF-κB and initiates tumour vascular normalization
  著者:: Gan, Hui K, 等
  出版事項: (2009)
• IMMU-02. LOCOREGIONAL HER2CAR T CELLS FOR PEDIATRIC CENTRAL NERVOUS SYSTEM TUMORS: PRECLINICAL EFFICACY TO TOLERABILITY IN FIRST PATIENT
  著者:: Vitanza, Nicholas, 等
  出版事項: (2019)